1Sadhna Sharma,K. Saha,R. N. Shinghal,Gauri Bazaz Malik. Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour[J] 1991,Cancer Immunology Immunotherapy(3):198～202
2Jette Vibe-Petersen,Niels Tvede,Marcus Diamant,Anne Arnt Kjerulff,Hans Rahbek S?rensen,Vagn Andersen. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer[J] 1991,Cancer Immunology Immunotherapy(2):121～127
3Stephen C. Yang,Laurie Owen-Schaub,Elizabeth A. Grimm,Jack A. Roth. Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-α against primary lung cancer targets[J] 1989,Cancer Immunology Immunotherapy(3):193～198
4Keiji Nara,Hiroki Odagiri,Masahiko Fujii,Yuji Yamanaka,Masaki Yokoyama,Takayuki Morita,Mutsuo Sasaki,Mitsuru Kon,Toru Abo. Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma[J] 1987,Cancer Immunology Immunotherapy(2):126～132
